PAGANINI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 302
EU - Europa 81
AS - Asia 57
AF - Africa 1
Totale 441
Nazione #
US - Stati Uniti d'America 301
CN - Cina 29
UA - Ucraina 27
IT - Italia 14
DE - Germania 12
FI - Finlandia 9
HK - Hong Kong 8
SG - Singapore 7
IE - Irlanda 5
TR - Turchia 5
GB - Regno Unito 4
IN - India 4
SE - Svezia 4
FR - Francia 3
BE - Belgio 2
IR - Iran 2
BD - Bangladesh 1
CA - Canada 1
CH - Svizzera 1
KG - Kirghizistan 1
MU - Mauritius 1
Totale 441
Città #
Fairfield 53
Ashburn 48
Wilmington 22
Houston 21
Woodbridge 19
Ann Arbor 18
Jacksonville 18
Cambridge 16
Chandler 16
Seattle 16
Nanjing 10
Princeton 10
Beijing 8
Brescia 8
Helsinki 8
Hong Kong 8
Dublin 5
Kocaeli 5
New York 4
Washington 4
Shenyang 3
Brussels 2
Dearborn 2
Gunzenhausen 2
Jinan 2
San Diego 2
San Mateo 2
Singapore 2
Ardabil 1
Augusta 1
Bishkek 1
Des Moines 1
Dhaka 1
Hangzhou 1
Hanover 1
Hebei 1
Hefei 1
Ivry-sur-seine 1
Kunming 1
Lancaster 1
Lonate Ceppino 1
Los Angeles 1
Lumezzane 1
Orange 1
Pune 1
Redwood City 1
Rivoli 1
Sabz 1
Tianjin 1
Toronto 1
Walnut 1
Zhengzhou 1
Zurich 1
Totale 359
Nome #
Antiangiogenic effectiveness of the urokinase receptor- derived peptide UPARANT in a model of oxygen-induced retinopathy 126
N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors 118
Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases 114
FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress 60
β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism 39
Totale 457
Categoria #
all - tutte 2.464
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.464


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020104 11 1 4 11 6 10 10 14 11 9 5 12
2020/2021117 3 10 0 7 21 8 7 8 8 23 20 2
2021/202262 10 9 8 5 0 0 2 4 5 7 3 9
2022/202345 8 2 1 6 1 13 1 3 7 0 2 1
2023/202469 6 0 11 2 3 20 11 0 8 3 1 4
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 457